Electronics Guide

Magnetic Coupling Across the Barrier

Transcutaneous energy transfer relies on near-field magnetic induction. An alternating current in the external transmitting coil generates a time-varying magnetic field, a portion of which threads the implanted receiving coil and induces a voltage there. The skin and subcutaneous tissue between the coils are essentially transparent to the magnetic field at the frequencies used, so the field couples through the barrier without requiring any conductive path. The implanted coil feeds a rectifier and regulator that supply the device and, in most systems, charge an internal backup battery.

The Coupling Coefficient

The fraction of the transmitter's magnetic flux that links the receiver is captured by the coupling coefficient, a dimensionless number between zero and one. A separation of several millimeters to a centimeter or more of tissue, combined with the modest coil diameters that comfort and anatomy permit, yields a loosely coupled link whose coupling coefficient is well below unity. Loose coupling is the defining condition of transcutaneous transfer and shapes nearly every design decision, because much of the transmitted flux returns to the source without reaching the receiver.

Operating Frequency Selection

The choice of operating frequency balances competing effects. A higher frequency raises the voltage induced for a given coil and field, easing the transfer of power across a loosely coupled link, and it permits smaller coils and smaller compensating capacitors. A higher frequency, however, increases skin-effect and proximity-effect losses in the coil conductors, increases eddy-current losses in the implant's conductive housing and in surrounding tissue, and raises the rate at which tissue absorbs electromagnetic energy. Practical transcutaneous systems therefore operate in a band, broadly from the low hundreds of kilohertz to a few megahertz, that secures useful coupling while keeping tissue absorption and conductor losses manageable. Reported systems commonly sit between roughly one hundred kilohertz and a couple of megahertz. Some research links instead adopt an industrial, scientific, and medical band such as 6.78 or 13.56 megahertz, which simplifies emissions compliance but accepts the greater tissue absorption and conductor loss that the higher frequency brings.

Geometry and Alignment

Coil geometry sets the coupling that the link can achieve. Larger-diameter coils capture more mutual flux and tolerate greater separation, but the implanted coil's size is constrained by the anatomy of the implant pocket and by patient comfort. Coaxial alignment of the two coils maximizes coupling, yet the external coil, held against the skin by a garment or adhesive, inevitably shifts laterally and angularly during daily activity. Designers therefore optimize coil diameter and spacing to sustain adequate coupling across the realistic range of displacement rather than only at perfect alignment.

Conductor and Quality Factor

Because the link is loosely coupled, the quality factor of each coil strongly influences how much power reaches the load. High quality factor requires low conductor loss at the operating frequency, which is commonly achieved with litz wire whose many fine, individually insulated strands reduce the skin-effect and proximity-effect resistance that solid conductors would suffer. The implanted coil must additionally use biocompatible materials and a hermetic or biostable construction suited to permanent residence in the body.

Flux Guidance and Shielding

Some designs incorporate high-permeability magnetic material to guide flux toward the receiving coil and to shield nearby tissue and electronics from stray field. Any such material must be chosen for compatibility with the implant environment and for low loss at the operating frequency, since lossy magnetic material would itself heat. Conductive structures near the coils, including the metallic housing of the implant, perturb the field and induce eddy-current losses that the coil layout must account for.

Sources of Loss

End-to-end efficiency is the product of the efficiencies of the transmitter electronics, the coupled-coil link, and the receiver rectification and regulation. The coupled link is typically the limiting stage in a loosely coupled system, because flux that fails to link the receiver represents energy that circulates in the transmitter and dissipates in its resistance. The link efficiency a loosely coupled pair can reach is set by a single figure of merit, the product k²Q₁Q₂ of the squared coupling coefficient and the two coil quality factors. Maximum efficiency rises monotonically with that product and approaches unity only as the product grows large, which is why a design that cannot raise the coupling coefficient must instead raise the quality factors to compensate. Well-designed resonant transcutaneous links commonly target coil-to-coil efficiencies above eighty percent, though the overall figure from source to load is lower once the transmitter and receiver electronics are included; reported end-to-end efficiencies typically fall between sixty and eighty-five percent, with ventricular assist prototypes reaching roughly eighty percent under favorable alignment. Additional loss arises in the coil conductors, in any magnetic material, and through eddy currents induced in nearby conductive tissue and hardware.

The Thermal Constraint

The dissipated power that does not reach the load appears as heat, and in an implant that heat must be shed into surrounding tissue. Tissue tolerates only a modest temperature rise before cellular function is impaired, which places a hard ceiling on the loss that an implanted receiver and coil may dissipate. The governing standard for active implantable medical devices, ISO 14708-1, states the constraint explicitly: for a device not intended to supply heat, no outer surface may exceed the surrounding body temperature by more than 2 degrees Celsius unless a larger rise is specifically justified. That single figure converts an abstract biological concern into a concrete design budget, because the allowable dissipation follows directly from the implant's surface area and the thermal conductance of the tissue around it. This thermal limit, rather than any electrical limit, frequently bounds the power a transcutaneous system can deliver, and it is the reason efficiency is pursued as a safety requirement and not merely as an energy-conservation goal.

Managing Implant Temperature

Designers manage implant temperature by maximizing link efficiency, by spreading any unavoidable dissipation across a larger surface to lower local heat flux, and by siting heat-generating electronics where blood flow aids cooling. The external transmitter, freed from the tissue thermal limit, can dissipate more heat and can be cooled conventionally, so loss is preferentially shifted to the external side of the link wherever the system architecture allows.

Field Exposure and Absorption

The alternating magnetic field and the associated electric field deposit energy in tissue, and the resulting heating is quantified by the specific absorption rate, the power absorbed per unit mass of tissue, expressed in watts per kilogram. Specific absorption rate becomes a governing metric from about one hundred kilohertz upward, which is where the guidelines of the International Commission on Non-Ionizing Radiation Protection for radiofrequency exposure begin and where the corresponding IEEE standard, IEEE C95.1, likewise applies. Between one hundred kilohertz and ten megahertz, however, heating is not the only concern: the restrictions on induced internal electric field that guard against nerve and muscle stimulation remain in force alongside the absorption limits, so a transcutaneous link operating in that overlap band must satisfy both sets of restrictions. Above ten megahertz, heating alone governs.

The absorption limits themselves are stated as basic restrictions on averaged power deposition. For general-public exposure, the commission restricts whole-body average specific absorption rate to 0.08 watts per kilogram and localized specific absorption rate in the head and trunk to 2 watts per kilogram, the latter averaged over a 10-gram cubic mass of tissue and over a six-minute interval. Occupational limits are set five times higher. A transcutaneous system must keep both localized and whole-body absorption within the applicable limits across its full operating range, including the worst-case alignment that drives transmitter current highest. Because absorption for a given field strength rises with frequency, the specific absorption rate constraint reinforces the frequency choices discussed above.

Thermal Safety Margins

Beyond field absorption, direct conductive heating from the coils and electronics contributes to the total thermal load on tissue. Safe design treats the combined effect, keeping the steady-state temperature rise of skin and underlying tissue within bounds recognized to avoid injury, with margin for worst-case conditions such as poor coil alignment that increases transmitter current and stray field. Sustained operation rather than brief exposure governs the limit, because an implant powers a device continuously.

Electromagnetic Compatibility and Biological Effects

A transcutaneous link must neither interfere with nor be disrupted by other medical electronics, and it must not couple hazardous energy into co-located implanted leads or sensing circuits. The field strengths involved are evaluated against established guidance on human exposure to electromagnetic fields, and the system is designed so that foreseeable faults do not expose tissue to field levels or temperatures beyond the safe range.

Compensating the Coil Reactance

Each coil presents a large inductive reactance at the operating frequency, and a loosely coupled pair of bare coils transfers power poorly. Adding a capacitor to resonate with each coil at the operating frequency cancels the reactance, allowing large currents to circulate for a modest driving voltage and sharply increasing the power delivered across the gap. Resonant compensation is therefore standard in transcutaneous systems, applied on the transmitter side, the receiver side, or both.

Tolerance to Misalignment and Distance

Resonant operation also improves the link's tolerance to the changing geometry of a worn external coil. A well-designed resonant link sustains useful power transfer across a range of separations and lateral offsets where a non-resonant link would collapse. This robustness directly addresses the central practical difficulty of transcutaneous transfer, namely that the coupling coefficient varies continuously as the patient moves.

Tuning, Detuning, and Control

The resonant frequency depends on coil inductance and on the compensating capacitance, both of which can drift with temperature, with the proximity of conductive tissue and hardware, and with coil displacement. Systems accommodate this drift through adaptive control that adjusts the drive frequency or the transmitter operating point to track resonance, and through feedback from the implant that reports received voltage so the transmitter can deliver only the power the implant currently needs. Such closed-loop regulation maintains efficiency and prevents over-delivery of power as conditions change.

Ventricular Assist Devices

Mechanical circulatory support is the application that most demands transcutaneous transfer. A ventricular assist device drives a blood pump continuously and requires on the order of several watts: a contemporary continuous-flow pump such as the HeartMate 3 consumes roughly three to seven watts depending on speed and flow, with higher transient peaks. That is far more than an implantable battery could supply for a useful interval. Such devices draw power through a percutaneous driveline, a wire emerging through the skin, which is reliable but introduces a permanent infection risk at the exit site. Transcutaneous energy transfer aims to power the pump and recharge an internal backup battery across intact skin, removing the driveline and its infection burden while retaining a battery reserve to bridge interruptions of the external link.

Two fully implantable, transcutaneously powered systems have reached clinical use. The Arrow LionHeart LVD-2000, first implanted in 1999, was the first completely implanted left ventricular assist device intended for permanent support and received a CE mark in November 2003. The AbioCor total artificial heart, also powered across intact skin by a transcutaneous link, received a humanitarian device exemption from the United States Food and Drug Administration in 2006. Neither survived commercially: the LionHeart program was discontinued shortly after certification, and the AbioCor was likewise withdrawn. Both programs were limited by device durability and by the small patient populations they served rather than by any single failure of the energy-transfer link. No transcutaneously powered circulatory support system is in routine clinical use today, and the percutaneous driveline remains the standard means of powering these pumps, so transcutaneous transfer for this application is an active development goal informed by earlier clinical experience rather than current practice.

Rechargeable Implant Recharging

A broad class of rechargeable implants, including certain neurostimulators and other therapeutic devices, uses transcutaneous transfer not for continuous powering but for periodic recharging of an internal battery. The patient applies the external coil for a recharge session lasting from minutes to a few hours, after which the implant runs from its battery until the next session. This intermittent use relaxes the continuous thermal constraint somewhat but still requires that recharge-session heating remain within safe limits.

Low-Power and Battery-Free Implants

Some implants draw little enough power that they can run directly from the inductive link whenever the external coil is present, dispensing with an internal battery altogether. Conventional pacemakers do not require transcutaneous powering, because their microwatt-level consumption is met for about a decade by a primary lithium cell; the relevance of inductive coupling to such devices lies historically in telemetry and, more recently, in research toward battery-free and rechargeable designs. Battery-free architectures suit implants that need not operate when the external unit is absent and that benefit from the smallest possible implanted volume.

Infection and Mechanical Reliability

A percutaneous lead carries power inward through a permanent opening in the skin, and that opening never fully heals, providing a route for bacteria and a site of chronic irritation. Driveline infection is a leading source of complication in long-term circulatory support. The percutaneous wire is also subject to mechanical fatigue and damage where it crosses the skin and moves with the body. Transcutaneous transfer eliminates both hazards by carrying no conductor through the skin, which is its principal clinical motivation.

Efficiency, Reserve, and Convenience

The percutaneous lead transfers power with very high efficiency and imposes no tissue-heating limit, advantages that a loosely coupled inductive link cannot match. Transcutaneous systems therefore accept lower efficiency and a bounded power capability, and they incorporate an implanted backup battery to sustain the device when the external coil is removed, for instance during bathing or while sleeping. The patient must wear and maintain the external transmitter and keep it reasonably aligned, a burden the percutaneous approach avoids.

Engineering Trade-Off

The comparison reduces to a trade between a wire that is efficient but breaches the skin and a field that preserves the skin but transfers power less efficiently and with thermal limits. For high-power, long-duration implants, the infection and reliability advantages of an intact skin barrier increasingly justify the added complexity and the efficiency penalty of transcutaneous transfer, while lower-power implants may favor either approach depending on their power budget and required runtime.